Patent details

EP2046337 Title: SOLID FORMS CONTAINING MELOXICAM WITH IMPROVED BUCCAL TASTE AND PROCESS FOR THEIR PREPARATION

Basic Information

Publication number:
EP2046337
PCT Application Number:
EP2007055706
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077300481
PCT Publication Number:
WO2007144323
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID FORMS CONTAINING MELOXICAM WITH IMPROVED BUCCAL TASTE AND PROCESS FOR THEIR PREPARATION
French Title of Invention:
FORMES SOLIDES CONTENANT DU MÉLOXICAM AYANT UN GOUT BUCCAL AMÉLIORÉ ET PROCÉDÉ POUR LEUR PRÉPARATION
German Title of Invention:
MELOXICAM ENTHALTENDE FESTE FORMEN MIT VERBESSERTEM BUKKALEN GESCHMACK UND HERSTELLUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
11/06/2007
Grant date:
19/07/2017
EP Publication Date:
15/04/2009
PCT Publication Date:
21/12/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/07/2017
EP B1 Publication Date:
19/07/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/06/2018
Expiration date:
11/06/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2017
 
 

Name:
Alpex Pharma SA
Address:
Via Cantonale, 6805 Mezzovico, Switzerland (CH)

Inventor

1

Name:
ARDALAN, Shahbaz
Address:
Switzerland (CH)

2

Name:
STROPPOLO, Federico
Address:
Switzerland (CH)

Priority

Priority Number:
06012353
Priority Date:
15/06/2006
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/20; A61K 31/5415;

Publication

European Patent Bulletin

Issue number:
201729
Publication date:
19/07/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1